Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Nov 28;25:49–60. doi: 10.1016/j.reth.2023.11.010

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Fig. 9 — Histological analysis after 21 days of implantation in the femoral head: (a) CaP/CMC, (b) 3mixCaP, (c) CaP/PEI/pVEGF/SiO₂, (d) CaP/PEI/pBMP-7/SiO₂, and (e) CaP/PEI/siRNA- TNF-α/SiO₂. The asterisk shows remaining implanted material (CaP). Scale bars: 1600 μm in low magnification of Hematoxylin and Eosin and 100 μm in high magnification of Hematoxylin and Eosin, TNF-α, OCN, Runx2 and SP-7.

Fig. 9 — Histological analysis after 21 days of implantation in the femoral head: (a) CaP/CMC, (b) 3mixCaP, (c) CaP/PEI/pVEGF/SiO₂, (d) CaP/PEI/pBMP-7/SiO₂, and (e) CaP/PEI/siRNA- TNF-α/SiO₂. The asterisk shows remaining implanted material (CaP). Scale bars: 1600 μm in low magnification of Hematoxylin and Eosin and 100 μm in high magnification of Hematoxylin and Eosin, TNF-α, OCN, Runx2 and SP-7.